363
Views
8
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation

, , , , , , , , & show all
Pages 103-109 | Received 18 Feb 2015, Accepted 23 Apr 2015, Published online: 25 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Boglarka Gyurkocza, Rainer Storb, Thomas R. Chauncey, David G. Maloney, Barry E. Storer & Brenda M. Sandmaier. (2019) Second allogeneic hematopoietic cell transplantation for relapse after first allografts. Leukemia & Lymphoma 60:7, pages 1758-1766.
Read now
Takayoshi Tachibana, Kenji Matsumoto, Masatsugu Tanaka, Maki Hagihara, Kenji Motohashi, Wataru Yamamoto, Eriko Ogusa, Satoshi Koyama, Ayumi Numata, Naoto Tomita, Jun Taguchi, Shin Fujisawa, Heiwa Kanamori & Hideaki Nakajima. (2017) Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation. Leukemia & Lymphoma 58:6, pages 1403-1411.
Read now

Articles from other publishers (6)

Yufeng Du, Chunhong Li, Zhijia Zhao, Yikun Liu, Chengtao Zhang & Jinsong Yan. (2023) Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. BMC Cancer 23:1.
Crossref
Mohamed A. Kharfan-Dabaja, Tea Reljic, Farah Yassine, Taiga Nishihori, Arni Kumar, Mitchell M. Tawk, Katelyn Keller, Ernesto Ayala, Bipin Savani, Mohamad Mohty, Mahmoud Aljurf & Wael Saber. (2022) Efficacy of a Second Allogeneic Hematopoietic Cell Transplant in Relapsed Acute Myeloid Leukemia: Results of a Systematic Review and Meta-Analysis. Transplantation and Cellular Therapy 28:11, pages 767.e1-767.e11.
Crossref
Takaaki Konuma, Shohei Mizuno, Kaito Harada, Naoyuki Uchida, Satoshi Takahashi, Tetsuya Eto, Shuichi Ota, Hikaru Kobayashi, Yuta Katayama, Yasuo Mori, Yumiko Maruyama, Makoto Onizuka, Akihito Yonezawa, Toshiro Kawakita, Takafumi Kimura, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta & Masamitsu Yanada. (2022) Reducing Mortality of Single-Unit Unrelated Cord Blood Transplantation for Relapsed Acute Myeloid Leukemia after a Previous Allogeneic Transplantation: A Real-World Retrospective Study Over the Past 19 Years in Japan. Transplantation and Cellular Therapy 28:11, pages 777.e1-777.e11.
Crossref
Takaaki Konuma, Maki Monna‐Oiwa, Masamichi Isobe, Motohito Okabe, Satoshi Takahashi & Arinobu Tojo. (2021) Radiation‐free myeloablative conditioning consisting of fludarabine added to full‐dose busulfan and cyclophosphamide in single‐unit cord blood transplantation for adults. European Journal of Haematology 107:3, pages 374-376.
Crossref
Satoshi Kaito, Atsushi Wada, Hiroto Adachi, Ryosuke Konuma, Yuya Kishida, Akihito Nagata, Tatsuya Konishi, Yuta Yamada, Takuma Kumagai, Kota Yoshifuji, Junichi Mukae, Megumi Akiyama, Kyoko Inamoto, Takashi Toya, Aiko Igarashi, Yuho Najima, Hideharu Muto, Takeshi Kobayashi, Kazuhiko Kakihana, Kazuteru Ohashi, Hisashi Sakamaki & Noriko Doki. (2020) Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation. Annals of Hematology 99:7, pages 1655-1665.
Crossref
Barbara Spitzer, Miguel-Angel Perales, Nancy A. Kernan, Susan E. Prockop, Emily C. Zabor, Nicholas Webb, Hugo Castro-Malaspina, Esperanza B. Papadopoulos, James W. Young, Andromachi Scaradavou, Rachel Kobos, Sergio A. Giralt, Richard J. O'Reilly & Farid Boulad. (2016) Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa. Biology of Blood and Marrow Transplantation 22:8, pages 1449-1454.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.